Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Inhibition of mast cell degranulation by a chimeric toxin containing a novel phosphatidylinositol-3,4,5-triphosphate phosphatase.

Shenker BJ, Boesze-Battaglia K, Zekavat A, Walker L, Besack D, Ali H.

Mol Immunol. 2010 Nov-Dec;48(1-3):203-10. doi: 10.1016/j.molimm.2010.08.009. Epub 2010 Sep 21.

2.

PIP3 regulation as promising targeted therapy of mast-cell-mediated diseases.

Shenker BJ, Ali H, Boesze-Battaglia K.

Curr Pharm Des. 2011 Nov;17(34):3815-22. Review.

PMID:
22103853
3.

Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate.

Shenker BJ, Walker LP, Zekavat A, Boesze-Battaglia K.

Mol Oral Microbiol. 2016 Feb;31(1):33-42. doi: 10.1111/omi.12127. Epub 2015 Sep 24.

4.

The PH domain adaptor protein Bam32/DAPP1 functions in mast cells to restrain FcɛRI-induced calcium flux and granule release.

Hou S, Pauls SD, Liu P, Marshall AJ.

Mol Immunol. 2010 Nov-Dec;48(1-3):89-97. doi: 10.1016/j.molimm.2010.09.007. Epub 2010 Oct 16.

PMID:
20956018
5.

Regulation of M2-type pyruvate kinase mediated by the high-affinity IgE receptors is required for mast cell degranulation.

Ryu H, Walker JK, Kim S, Koo N, Barak LS, Noguchi T, Kang BY, Kim KM.

Br J Pharmacol. 2008 Jul;154(5):1035-46. doi: 10.1038/bjp.2008.148. Epub 2008 Apr 21.

6.

The toxicity of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin correlates with its phosphatidylinositol-3,4,5-triphosphate phosphatase activity.

Shenker BJ, Boesze-Battaglia K, Scuron MD, Walker LP, Zekavat A, Dlakić M.

Cell Microbiol. 2016 Feb;18(2):223-43. doi: 10.1111/cmi.12497. Epub 2015 Sep 2.

PMID:
26247396
7.

Inhibitory effect of carotenoids on the degranulation of mast cells via suppression of antigen-induced aggregation of high affinity IgE receptors.

Sakai S, Sugawara T, Matsubara K, Hirata T.

J Biol Chem. 2009 Oct 9;284(41):28172-9. doi: 10.1074/jbc.M109.001099. Epub 2009 Aug 21.

8.

Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release.

Kuehn HS, Beaven MA, Ma HT, Kim MS, Metcalfe DD, Gilfillan AM.

Cell Signal. 2008 Apr;20(4):625-36. doi: 10.1016/j.cellsig.2007.11.016. Epub 2008 Jan 22.

9.

A differential role for ceramide kinase in antigen/FcɛRI-mediated mast cell activation and function.

Hewson CA, Watson JR, Liu WL, Fidock MD.

Clin Exp Allergy. 2011 Mar;41(3):389-98. doi: 10.1111/j.1365-2222.2010.03682.x. Epub 2011 Jan 24.

PMID:
21255156
10.

FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.

Safaralizadeh R, Soheili ZS, Deezagi A, Pourpak Z, Samiei S, Moin M.

Iran J Allergy Asthma Immunol. 2009 Dec;8(4):177-83. doi: 08.04/ijaai.177183.

11.

Silver Nanoparticle-Directed Mast Cell Degranulation Is Mediated through Calcium and PI3K Signaling Independent of the High Affinity IgE Receptor.

Alsaleh NB, Persaud I, Brown JM.

PLoS One. 2016 Dec 1;11(12):e0167366. doi: 10.1371/journal.pone.0167366. eCollection 2016.

12.

A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells.

Kasakura K, Takahashi K, Aizawa T, Hosono A, Kaminogawa S.

Int Arch Allergy Immunol. 2009;150(4):359-69. doi: 10.1159/000226237. Epub 2009 Jul 1.

PMID:
19571568
13.

Comparison of inhibitory activities of zinc oxide ultrafine and fine particulates on IgE-induced mast cell activation.

Yamaki K, Yoshino S.

Biometals. 2009 Dec;22(6):1031-40. doi: 10.1007/s10534-009-9254-z.

PMID:
19609684
14.

Blockade of the PI-3K signalling pathway by the Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces macrophages to synthesize and secrete pro-inflammatory cytokines.

Shenker BJ, Walker LP, Zekavat A, Dlakić M, Boesze-Battaglia K.

Cell Microbiol. 2014 Sep;16(9):1391-404. doi: 10.1111/cmi.12299. Epub 2014 May 1.

15.

Enhanced mast cell activation in mice deficient in the A2b adenosine receptor.

Hua X, Kovarova M, Chason KD, Nguyen M, Koller BH, Tilley SL.

J Exp Med. 2007 Jan 22;204(1):117-28. Epub 2007 Jan 2. Erratum in: J Exp Med. 2007 Apr 16;204(4):963.

16.

SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells.

McPherson VA, Sharma N, Everingham S, Smith J, Zhu HH, Feng GS, Craig AW.

J Immunol. 2009 Oct 15;183(8):4940-7. doi: 10.4049/jimmunol.0900702. Epub 2009 Sep 28.

17.

A BASH/SLP-76-related adaptor protein MIST/Clnk involved in IgE receptor-mediated mast cell degranulation.

Goitsuka R, Kanazashi H, Sasanuma H, Fujimura Y, Hidaka Y, Tatsuno A, Ra C, Hayashi K, Kitamura D.

Int Immunol. 2000 Apr;12(4):573-80.

PMID:
10744659
18.

Prolonged culture of mast cells with high-glucose medium enhances the Fc epsilon RI-mediated degranulation response and leukotriene C4 production.

Kitahata Y, Nunomura S, Terui T, Ra C.

Int Arch Allergy Immunol. 2010;152 Suppl 1:22-31. doi: 10.1159/000312122. Epub 2010 Jun 4.

PMID:
20523060
19.

Selinidin suppresses IgE-mediated mast cell activation by inhibiting multiple steps of Fc epsilonRI signaling.

Kishiro S, Nunomura S, Nagai H, Akihisa T, Ra C.

Biol Pharm Bull. 2008 Mar;31(3):442-8.

20.

SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation.

Damen JE, Ware MD, Kalesnikoff J, Hughes MR, Krystal G.

Blood. 2001 Mar 1;97(5):1343-51.

Supplemental Content

Support Center